SR

Saad G. Rahim

GW Glaxo Wellcome: 6 patents #12 of 449Top 3%
BW Burroughs Wellcome: 5 patents #33 of 312Top 15%
SL Smithkline Beecham Limited: 3 patents #419 of 1,624Top 30%
📍 Sydenham, GB: #4 of 98 inventorsTop 5%
Overall (All Time): #354,509 of 4,157,543Top 9%
14
Patents All Time

Issued Patents All Time

Showing 1–14 of 14 patents

Patent #TitleCo-InventorsDate
7704971 Uracil reductase inactivators Thomas Spector, David J. T. Porter 2010-04-27
7119096 Uracil reductase inactivators Thomas Spector, David J. T. Porter 2006-10-10
6586440 Pharmaceutical compositions of 5-alkynyl uracil compounds Thomas Spector, David J. T. Porter 2003-07-01
6297223 Uracil reductase inactivatores Thomas Spector, David J. T. Porter 2001-10-02
6268374 Uracil reductase inactivators Thomas Spector, David J. T. Porter 2001-07-31
6221852 Pharmaceutical compositions of 5-alkynyl-dideoxyribouracil Thomas Spector, David J. T. Porter 2001-04-24
6177436 Pharmaceutical compositions of 5-alkynyl uracil compounds Thomas Spector, David J. T. Porter 2001-01-23
5817664 Uracil reductase inactivators Thomas Spector, David J. T. Porter 1998-10-06
5643913 Pharmaceutical compositions of 5-substituted uracil compounds Thomas Spector, David J. T. Porter 1997-07-01
5198539 5'-esters of 2',3'-dideoxy-3'-fluoro-5-ethynyluridine Thomas A. Krenitsky 1993-03-30
5157114 2',3'-dideoxy-3'-fluoro-5-ethyngluridine Thomas A. Krenitsky 1992-10-20
5079235 Antiviral compounds Dorothy J. M. Purifoy 1992-01-07
5028596 1-(.beta.-D-arabinofuranosyl)-5-propynyluracil for treatment of VZV infections Dorothy J. M. Purifoy 1991-07-02
4863906 2'-deoxy-5-ethynyluridine-3',5'-diestens for treatment of VZV and CMV infections John W. T. Selway 1989-09-05